Laval, Canada

Jean-Nicholas Mess

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Larimar Therapeutics, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Nicholas Mess. Retrieved from https://idiyas.com/inventor/jean-nicholas-mess

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean-Nicholas Mess: Innovator in Frataxin Research

Introduction

Jean-Nicholas Mess is a notable inventor based in Laval, Canada. He has made significant contributions to the field of biochemistry, particularly in the study of frataxin and its related proteins. His work has implications for understanding certain genetic disorders and developing potential therapies.

Latest Patents

Jean-Nicholas Mess holds a patent titled "Methods of Quantifying Frataxin and Frataxin Fusion Proteins." This patent represents his innovative approach to measuring frataxin levels, which is crucial for research into related diseases.

Career Highlights

Throughout his career, Mess has worked with various organizations, including Larimar Therapeutics, Inc. and the United States of America, as represented by the Secretary, Department of Health and Human Services. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

He has collaborated with notable colleagues such as Erik Johan Wagner and Xin Xu. These partnerships have enriched his research and expanded the impact of his work in the field.

Conclusion

Jean-Nicholas Mess is a dedicated inventor whose work in frataxin research continues to influence the scientific landscape. His contributions are vital for advancing our understanding of genetic disorders and developing new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…